342 related articles for article (PubMed ID: 31420888)
1. Fertility preservation in Turner syndrome: Karyotype does not predict ovarian response to stimulation.
Vergier J; Bottin P; Saias J; Reynaud R; Guillemain C; Courbiere B
Clin Endocrinol (Oxf); 2019 Nov; 91(5):646-651. PubMed ID: 31420888
[TBL] [Abstract][Full Text] [Related]
2. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
[TBL] [Abstract][Full Text] [Related]
3. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments.
Oktay K; Bedoschi G
J Pediatr Adolesc Gynecol; 2014 Dec; 27(6):342-6. PubMed ID: 25214440
[TBL] [Abstract][Full Text] [Related]
4. First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome.
Strypstein L; Van Moer E; Nekkebroeck J; Segers I; Tournaye H; Demeestere I; Dolmans MM; Verpoest W; De Vos M
J Assist Reprod Genet; 2022 Feb; 39(2):543-549. PubMed ID: 35122176
[TBL] [Abstract][Full Text] [Related]
5. DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
Ito A; Katagiri Y; Tamaki Y; Fukuda Y; Oji A; Morita M
Gynecol Endocrinol; 2020 Dec; 36(12):1144-1148. PubMed ID: 32945708
[TBL] [Abstract][Full Text] [Related]
6. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
7. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
8. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
Talaulikar VS; Conway GS; Pimblett A; Davies MC
Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone levels in patients with turner syndrome: Relation to karyotype, spontaneous puberty, and replacement therapy.
Hamza RT; Mira MF; Hamed AI; Ezzat T; Sallam MT
Am J Med Genet A; 2018 Sep; 176(9):1929-1934. PubMed ID: 30088853
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment.
Visser JA; Hokken-Koelega AC; Zandwijken GR; Limacher A; Ranke MB; Flück CE
Hum Reprod; 2013 Jul; 28(7):1899-907. PubMed ID: 23539612
[TBL] [Abstract][Full Text] [Related]
11. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Fertility Preservation Consults for Women at Risk for Primary Ovarian Insufficiency Due to History of Cancer Treatment or Mosaic Turner Syndrome.
Ulrich ND; Raja N; Ellman E; Moravek MB
J Adolesc Young Adult Oncol; 2022 Aug; 11(4):427-432. PubMed ID: 34550775
[TBL] [Abstract][Full Text] [Related]
13. Oocyte cryopreservation in a woman with mosaic Turner syndrome: a case report.
Kavoussi SK; Fisseha S; Smith YR; Smith GD; Christman GM; Gago LA
J Reprod Med; 2008 Mar; 53(3):223-6. PubMed ID: 18441731
[TBL] [Abstract][Full Text] [Related]
14. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
[TBL] [Abstract][Full Text] [Related]
15. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
16. Navigating fertility dilemmas across the lifespan in girls with Turner syndrome-a scoping review.
van der Coelen S; van der Velden J; Nadesapillai S; Braat D; Peek R; Fleischer K
Hum Reprod Update; 2024 Mar; ():. PubMed ID: 38452347
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of fertility preservation in young females with Turner syndrome.
Lau NM; Huang JY; MacDonald S; Elizur S; Gidoni Y; Holzer H; Chian RC; Tulandi T; Tan SL
Reprod Biomed Online; 2009 Feb; 18(2):290-5. PubMed ID: 19192353
[TBL] [Abstract][Full Text] [Related]
18. Trends and outcomes of fertility preservation for girls, adolescents and young adults with Turner syndrome: A prospective cohort study.
Rodriguez-Wallberg KA; Sergouniotis F; Nilsson HP; Lundberg FE
Front Endocrinol (Lausanne); 2023; 14():1135249. PubMed ID: 36936144
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
Ciccarone M; Hohaus S; Pulsoni A; Cavaceppi P; Franzò S; Fabbri R; Cudillo L; Battistini R; Di Rocco A; Annibali O; Cox MC; Provenzano I; Abruzzese E; Renzi D; Tesei C; Anticoli Borza P; Cuccaro A; Andriani A; D'Elia GM; Facchiano A; Marchetti P; Cantonetti M
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13174. PubMed ID: 31571303
[TBL] [Abstract][Full Text] [Related]
20. AMH as Predictor of Premature Ovarian Insufficiency: A Longitudinal Study of 120 Turner Syndrome Patients.
Lunding SA; Aksglaede L; Anderson RA; Main KM; Juul A; Hagen CP; Pedersen AT
J Clin Endocrinol Metab; 2015 Jul; 100(7):E1030-8. PubMed ID: 25978111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
